Samalizumab
Product Specifications
CAS Number
1073059-33-2
Target
Immunology/Inflammation related
Related Pathways
Immunology/Inflammation
Purity
0.9564
Bioactivity
Samalizumab (ALXN 6000) is a humanized anti-CD200 monoclonal antibody that specifically targets the CD200 immunoregulatory cell surface protein, a member of the immunoglobulin superfamily which functions to dampen excessive immune responses and maintain self-tolerance, thereby establishing Samalizumab as an effective immune checkpoint inhibitor currently under investigation for the treatment of myeloma and B-cell chronic lymphocytic leukemia (CLL) .
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
A60-110P 1 mg
Goal anli-Guinea Pig IgG Heavy and Light Chain Antibody HRP Conjugated
Ask
View Details 
K0199-11G-HRP 200 µL
KRT10, ID (Keratin, Type I Cytoskeletal 10, Cytokeratin-10, CK-10, Keratin-10, K10, KPP) (HRP) discontinued
Ask
View Details 